| 000 | 01888cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 100504s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2009.Di.C | ||
| 100 | 0 | _aDina Elsaid Abdelsalam Ahmed | |
| 245 | 1 | 0 |
_aComparison between progenitor subsets and functional properties of bone marrow and leukapheresis derived mesenchmal stem cells / _cDina Elsaid Abdelsalam Ahmed ; Supervised Hala Gabr Metwally , Somaia Abdelrahman Mousa , Raft Mohammed Abdelfatah |
| 246 | 1 | 5 | _aمقارنة بين مزنشيمى الخلايا الجذعية المشتقة من كل من النخاع العظمى وكرات الدم البيضاء من حيث النسب والخصائص الوظيفية |
| 260 |
_aCairo : _bDina Elsaid Abdelsalam Ahmed , _c2009 |
||
| 300 |
_a106P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aMesenchymal stem cells (MSCs ) have high proliferative and differentiation potential in addition to their plasticity that makes them promising candidates for cell therapeutic applications . Bone marrow (BM ) harvest is still the main source of MSCs in spite of being traumatic and painful . Clinical indications for peripheral blood (PB ) - derived MSCs, which can be easily and safely harvested are rapidly increasing | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBone marrow | |
| 653 | 4 | _aMesenchymal stem cells | |
| 653 | 4 | _aStem cells | |
| 700 | 0 |
_aHala Gabr Metwally , _eSupervisor |
|
| 700 | 0 |
_aRaft Mohammed Abdelfatah , _eSupervisor |
|
| 700 | 0 |
_aSomaia Abdelrahman Mousa , _eSupervisor |
|
| 902 | _a1 | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30199 _d30199 |
||